These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36297490)

  • 21. Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods.
    Kashiwagura Y; Takusagawa S; Ikematsu Y; Tanaka S; Namiki N; Uchida S
    Acta Pharm; 2023 Mar; 73(1):107-119. PubMed ID: 36692467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
    Petrovick GF; Kleinebudde P; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Jan; 122():137-145. PubMed ID: 29106946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tablet compression tooling - Impact of punch face edge modification.
    Anbalagan P; Heng PWS; Liew CV
    Int J Pharm; 2017 May; 524(1-2):373-381. PubMed ID: 28389365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and evaluation of orally disintegrating tablets containing vitamin E as a model fat-soluble drug.
    Ikematsu Y; Uchida S; Namiki N
    Chem Pharm Bull (Tokyo); 2015; 63(3):156-63. PubMed ID: 25757486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Punch geometry and formulation considerations in reducing tablet friability and their effect on in vitro dissolution.
    Chowhan ZT; Amaro AA; Ong JT
    J Pharm Sci; 1992 Mar; 81(3):290-4. PubMed ID: 1640370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges and emerging solutions in the development of compressed orally disintegrating tablets.
    Al-Khattawi A; Mohammed AR
    Expert Opin Drug Discov; 2014 Oct; 9(10):1109-20. PubMed ID: 25045997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of Cocoa Powder-Containing Orally Disintegrating Tablets of Rebamipide (Rebamipide Chocolet) and Evaluation of Their Clinical Palatability.
    Takano H; Uchida S; Kashiwagura Y; Tanaka S; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
    Chem Pharm Bull (Tokyo); 2019; 67(2):112-119. PubMed ID: 30713270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology.
    Zhang Y; Li Z; Tang H; Ren W; Gao X; Sun Y; Zhao QX; Wang F; Liu J
    Drug Dev Ind Pharm; 2020 Jan; 46(1):42-49. PubMed ID: 31794271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The practical approach to the evaluation of methods used to determine the disintegration time of orally disintegrating tablets (ODTs).
    Brniak W; Jachowicz R; Pelka P
    Saudi Pharm J; 2015 Sep; 23(4):437-43. PubMed ID: 27134547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling of adhesion in tablet compression. II. Compaction studies using a compaction simulator and an instrumented tablet press.
    Wang JJ; Guillot MA; Bateman SD; Morris KR
    J Pharm Sci; 2004 Feb; 93(2):407-17. PubMed ID: 14705197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the Punch Head Design on the Physical Quality of Tablets Produced in a Rotary Press.
    Anbalagan P; Sarkar S; Liew CV; Heng PWS
    J Pharm Sci; 2017 Jan; 106(1):356-365. PubMed ID: 27842972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of repeated compaction of tablets on tablet properties and work of compaction using an instrumented laboratory tablet press.
    Gamlen MJ; Martini LG; Al Obaidy KG
    Drug Dev Ind Pharm; 2015 Jan; 41(1):163-9. PubMed ID: 24171692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A material sparing test to predict punch sticking during formulation development.
    Simmons DM; Gierer DS
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1054-60. PubMed ID: 22181042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.
    Gowda V; Pabari RM; Kelly JG; Ramtoola Z
    Pharm Dev Technol; 2015 Jun; 20(4):394-400. PubMed ID: 24397821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of the API properties on the ODTs manufacturing from co-processed excipient systems.
    Krupa A; Jachowicz R; Pędzich Z; Wodnicka K
    AAPS PharmSciTech; 2012 Dec; 13(4):1120-9. PubMed ID: 22941425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of the Modified Ocimum gratissimum Seeds for Orally Disintegrating Tablets.
    Dang YNT; Tran PHL; Tran TTD
    Recent Pat Drug Deliv Formul; 2020; 14(1):40-47. PubMed ID: 31660821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
    Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orally-disintegrating Tablets in Fixed-dose Combination Containing Ambroxol Hydrochloride and Salbutamol Sulphate Prepared by Direct Compression: Formulation Design, Development and
    Sharma D; Singh R; Singh G
    Turk J Pharm Sci; 2018 Apr; 15(1):29-37. PubMed ID: 32454637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.
    Nausieda PA; Pfeiffer RF; Tagliati M; Kastenholz KV; DeRoche C; Slevin JT
    Clin Ther; 2005 Jan; 27(1):58-63. PubMed ID: 15763606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.